How to buy Altimmune (ALT) shares in Australia
Learn how to easily invest in Altimmune shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Altimmune Inc is a biotechnology business with stocks listed in the US. Altimmune shares (ALT) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$9.79 – a decrease of 0.61% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in Altimmune
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Altimmune. Find the share by name or ticker symbol: ALT. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Altimmune reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$9.79, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Altimmune, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Altimmune. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Altimmune stock price (NASDAQ:ALT)Use our graph to track the performance of ALT stocks over time.
Altimmune shares at a glance
|52-week range||US$8.1 - US$24.61|
|50-day moving average||US$11.4758|
|200-day moving average||US$12.9126|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$-2.11|
Where to buy Altimmune stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Altimmune stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Considering buying Altimmune shares?Before you consider Altimmune, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.
Show me how
Altimmune price performance over time
|1 week (2021-12-02)||-3.26%|
|1 month (2021-11-09)||-10.35%|
|3 months (2021-09-09)||-40.30%|
|6 months (2021-06-09)||-35.29%|
|1 year (2020-12-09)||-20.47%|
|2 years (2019-12-09)||432.07%|
|3 years (2018-12-07)||206.90%|
|5 years (2016-12-09)||-98.98%|
Stocks similar to Altimmune
|Revenue TTM||US$3.4 million|
|Gross profit TTM||US$-25,324,291|
|Return on assets TTM||-21.31%|
|Return on equity TTM||-40.99%|
|Market capitalisation||US$402.2 million|
TTM: trailing 12 months
Altimmune share dividends
We're not expecting Altimmune to pay a dividend over the next 12 months.
Have Altimmune's shares ever split?
Altimmune's shares were split on a 1:30 basis on 13 September 2018. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Altimmune shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Altimmune shares which in turn could have impacted Altimmune's share price.
Altimmune share price volatility
Over the last 12 months, Altimmune's shares have ranged in value from as little as US$8.1 up to US$24.61. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Altimmune's is 1.4028. This would suggest that Altimmune's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing intranasal vaccines, immune modulating therapies, and treatments for liver disease. The company develops AdCOVID, a single-dose intranasal vaccine that is in Phase I clinical trial to protect against COVID-19; T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase I/II clinical trial to evaluate the potential of T-COVID to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate, which completed Phase IIa clinical trial for the treatment of seasonal and pandemic use. It also focuses on developing ALT-801, a novel peptide-based dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis that is in Phase I clinical trial; and HepTcell, an immunotherapeutic product candidate, which is in Phase II clinical trial for patients chronically infected with the hepatitis B virus. Altimmune, Inc. has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. The company is headquartered in Gaithersburg, Maryland.
Altimmune in the news
Altimmune : 5th NASH Summit 2021 Presentation
Altimmune to Present at Upcoming Investor and Scientific Conferences
Altimmune (ALT) Presents At 2021 Virtual Healthcare Conference - Slideshow
Frequently asked questions
More guides on Finder
The best products to achieve the clean beauty look
From where the no-makeup makeup look meets the model off duty vibe, we've put together a range of no-fuss products you'll love.
Where to watch Moulin Rouge! online in Australia
Every man wanted her – 1 man dared to love her.
How to watch Man United vs Arsenal Premier League live and match preview
Manchester United are scrambling to stay in touch with the top 4 as they host Arsenal this week
12-day advent calendars you can still get before Christmas
From toys to socks to beauty items, these are the top 12-day advent calendars you can still enjoy in the lead up to Christmas.
McDonald’s (MCD) share price, company profile and news
Steps to owning and managing McDonald's shares from in Australia.
Reputation & Christmas parties: Why I won’t be having a festive celebration this year
Reputation + Christmas parties: could it be the potential volcano erupting leaving rands, families and individuals to deal with the fallout?
Pay-as-you-groan: On-demand insurance that pays you $2K for a broken arm
Insurtech Flip has shaken up the insurance industry by launching the first on-demand injury cover in the country.
How to invest in the Qualitas Limited IPO
Everything we know about the Qualitas Limited IPO, plus information on how to buy in.
How to invest in the WA1 Resources IPO
Everything we know about the WA1 Resources IPO, plus information on how to buy in.
Ask an Expert